by CytoPrevent | Jul 19, 2021 | News
The trilogue process with the European Council, Parliament and Commission under the Portuguese Presidency concludes today and there has been no discussion at all on the important legislative changes to the Carcinogens and Mutagens Directive (CMD), passed by the...
by CytoPrevent | Apr 21, 2021 | News, What’s new on CytoPrevent
SUMMARY OF STUDY To reinforce protection of workers from exposure to hazardous medicinal products, including cytotoxic medicinal products: an Independent Group to European Commission made a study with different proposals The study was implemented during the period...
by CytoPrevent | Apr 13, 2021 | Board’s Position Papers, News
ANNOUNCEMENT Paris, 13th April 2021 The CytoPrevent board strongly supports the European Parliament vote to include hazardous drugs and reprotoxics in the Carcinogens and Mutagens...
by CytoPrevent | Apr 8, 2021 | What’s new on CytoPrevent
ANNOUNCEMENT Paris, 19th March Occupational exposure to hazardous drugs: European Scientific Advisory Board “CytoPrevent” launched to improve healthcare workers’ protection Today,...
by CytoPrevent | Mar 5, 2021 | Board’s Position Papers, News
Dear Madam, Sir, CytoPrevent, a group of scientific experts, would like to use the opportunity to give our comments and suggestions on “work involving exposure to cytostatic agents”. We appreciate the appraisal as a step forward to improve worker’s safety and health...